CohBar Appoints Steven B. Engle as Chief Executive Officer

May 7, 2019

CohBar to Resume its Phase 1a/1b Clinical Trial

May 3, 2019

CohBar to Announce 2019 First Quarter Financial Results and Provide Business Update on May 7, 2019

Apr 26, 2019

CohBar Announces Key Opinion Leader Conference Call and Webcast

Apr 23, 2019

CohBar Announces the Appointment of David Greenwood to its Board of Directors

Apr 22, 2019

CohBar Reports Fourth Quarter 2018 Financial Results and Provides Business Update

Mar 18, 2019

CohBar to Announce 2018 Fourth Quarter Financial Results and Host Conference Call on March 18, 2019

Mar 4, 2019

CohBar Announces the Appointment of Dr. Phyllis Gardner to its Board of Directors

Feb 11, 2019

CohBar Appoints Philippe P. Calais, Pharm.D., Ph.D. as Interim Chief Executive Officer

Dec 10, 2018

CohBar Founder Dr. Nir Barzilai Awarded the 2018 Fondation IPSEN Longevity Prize

Nov 26, 2018